ATE304011T1 - Hydantoin-enthaltende glucokinase aktivatoren - Google Patents

Hydantoin-enthaltende glucokinase aktivatoren

Info

Publication number
ATE304011T1
ATE304011T1 AT01925563T AT01925563T ATE304011T1 AT E304011 T1 ATE304011 T1 AT E304011T1 AT 01925563 T AT01925563 T AT 01925563T AT 01925563 T AT01925563 T AT 01925563T AT E304011 T1 ATE304011 T1 AT E304011T1
Authority
AT
Austria
Prior art keywords
glucocinase
activators
hydantoin containing
hydantoin
glucocinase activators
Prior art date
Application number
AT01925563T
Other languages
English (en)
Inventor
Robert Alan Goodnow Jr
Kang Le
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE304011T1 publication Critical patent/ATE304011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01925563T 2000-05-03 2001-04-23 Hydantoin-enthaltende glucokinase aktivatoren ATE304011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20149800P 2000-05-03 2000-05-03
PCT/EP2001/004555 WO2001083478A2 (en) 2000-05-03 2001-04-23 Hydantoin-containing glucokinase activators

Publications (1)

Publication Number Publication Date
ATE304011T1 true ATE304011T1 (de) 2005-09-15

Family

ID=22746054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01925563T ATE304011T1 (de) 2000-05-03 2001-04-23 Hydantoin-enthaltende glucokinase aktivatoren

Country Status (20)

Country Link
US (2) US6583288B2 (de)
EP (1) EP1280801B1 (de)
JP (1) JP3842131B2 (de)
KR (1) KR100505312B1 (de)
CN (1) CN1209361C (de)
AR (1) AR034253A1 (de)
AT (1) ATE304011T1 (de)
AU (2) AU5227001A (de)
BR (1) BR0110492A (de)
CA (1) CA2407428C (de)
DE (1) DE60113247T2 (de)
DK (1) DK1280801T3 (de)
EC (1) ECSP014055A (de)
ES (1) ES2248309T3 (de)
MX (1) MXPA02010746A (de)
PE (1) PE20011313A1 (de)
PT (1) PT1280801E (de)
UY (1) UY26689A1 (de)
WO (1) WO2001083478A2 (de)
ZA (1) ZA200208370B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5227001A (en) * 2000-05-03 2001-11-12 Hoffmann La Roche Hydantoin-containing glucokinase activators
US6482951B2 (en) 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
PL370989A1 (en) 2001-12-21 2005-06-13 Novo Nordisk A/S Amide derivatives as gk activators
RU2340605C2 (ru) 2002-06-27 2008-12-10 Ново Нордиск А/С Арилкарбонильные производные в качестве терапевтических средств
AU2003243921B2 (en) 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
BR0314864A (pt) 2002-10-03 2005-08-02 Novartis Ag Compostos orgânicos
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
US7262196B2 (en) * 2003-02-11 2007-08-28 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
CN1910166B (zh) * 2004-01-06 2012-01-04 诺和诺德公司 杂芳基脲及其作为葡糖激酶活化剂的用途
BRPI0506662B8 (pt) * 2004-01-06 2021-05-25 Novo Nordisk As compostos ativadores de glucoquinase
US7781451B2 (en) 2004-04-02 2010-08-24 Novartis Ag Thiazolopyridine derivatives, pharmaceut ical conditions containing them and methods of treating glucokinase mediated conditions
BRPI0509573A (pt) 2004-04-02 2007-09-25 Novartis Ag derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
BRPI0514515A (pt) * 2004-08-17 2008-06-10 Hoffmann La Roche hidantoìnas substituìdas
CN101014345A (zh) 2004-09-09 2007-08-08 默克公司 三环酰苯胺螺环内酰胺cgrp受体拮抗剂
US7390798B2 (en) * 2004-09-13 2008-06-24 Merck & Co., Inc. Carboxamide spirolactam CGRP receptor antagonists
CA2579847A1 (en) * 2004-09-13 2006-03-23 Merck & Co., Inc. Bicyclic anilide spirolactam cgrp receptor antagonists
TW200621766A (en) * 2004-09-17 2006-07-01 Hoffmann La Roche Substituted hydantoins
JP2009500377A (ja) 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス ジシクロアルキルウレア型グルコキナーゼ活性化剤
KR101346902B1 (ko) 2005-07-09 2014-01-02 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
EP1910317B1 (de) 2005-07-20 2013-07-03 Eli Lilly And Company 1-amino-verbundene verbindungen
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
CA2624102A1 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
ES2393757T3 (es) 2005-11-17 2012-12-27 Eli Lilly & Company Antagonistas de receptor de glucagón, preparación y usos terapéuticos
EP1948614A2 (de) * 2005-11-18 2008-07-30 Takeda San Diego, Inc. Glucokinaseaktivatoren
FR2894962B1 (fr) * 2005-12-20 2008-03-14 Pharmamens Sarl Hydantoines a action insulinotropique
US7612212B2 (en) * 2006-02-22 2009-11-03 Hoffmann-La Roche Inc. Substituted hydantoins
EP2001875A2 (de) * 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase-aktivatoren
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2049518B1 (de) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
TW200831081A (en) 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
JP5248477B2 (ja) * 2007-03-07 2013-07-31 杏林製薬株式会社 グルコキナーゼ活性化物質
JP2010521457A (ja) * 2007-03-12 2010-06-24 メルク・シャープ・エンド・ドーム・コーポレイション 単環式アニリドスピロラクタムｃｇｒｐ受容体アンタゴニスト
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
ATE551336T1 (de) * 2007-08-16 2012-04-15 Hoffmann La Roche Substituierte hydantoine
JP2011506533A (ja) 2007-12-20 2011-03-03 エフ．ホフマン−ラ ロシュ アーゲー Ｍｅｋキナーゼ阻害剤としての置換ヒダントイン
US8258134B2 (en) * 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
KR101608259B1 (ko) 2008-04-28 2016-04-01 교린 세이야꾸 가부시키 가이샤 시클로펜틸아크릴산아미드 유도체
KR20110018366A (ko) 2008-05-16 2011-02-23 다케다 샌디에고, 인코포레이티드 글루코키나아제 활성제
US8450494B2 (en) 2009-06-22 2013-05-28 Cadila Healthcare Limited Disubstituted benzamide derivatives as glucokinase (GK) activators
UA103807C2 (ru) 2009-07-31 2013-11-25 Кадила Хелткере Лимитед Замещенные бензамидные производные как активаторы глюкокиназы (gk)
CN102959076B (zh) 2010-03-31 2015-09-16 斯克里普斯研究所 重编程细胞
ES2671881B1 (es) * 2016-11-11 2019-03-25 Consejo Superior Investigacion Procedimiento de obtencion de polimeros con grupos isocianato
CN112040945A (zh) 2018-06-12 2020-12-04 Vtv治疗有限责任公司 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof
CA3181722A1 (en) 2020-06-08 2021-12-16 Jing TENG Salts or co-crystals of {2-[3-cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
AU5227001A (en) * 2000-05-03 2001-11-12 Hoffmann La Roche Hydantoin-containing glucokinase activators

Also Published As

Publication number Publication date
US20010056191A1 (en) 2001-12-27
UY26689A1 (es) 2001-11-30
ES2248309T3 (es) 2006-03-16
CA2407428A1 (en) 2001-11-08
AU5227001A (en) 2001-11-12
US20030225286A1 (en) 2003-12-04
EP1280801A2 (de) 2003-02-05
DE60113247D1 (de) 2005-10-13
WO2001083478A2 (en) 2001-11-08
WO2001083478A3 (en) 2002-05-16
DK1280801T3 (da) 2006-01-23
PE20011313A1 (es) 2001-12-28
DE60113247T2 (de) 2006-06-22
EP1280801B1 (de) 2005-09-07
MXPA02010746A (es) 2003-03-10
KR100505312B1 (ko) 2005-08-04
JP3842131B2 (ja) 2006-11-08
CN1427838A (zh) 2003-07-02
CN1209361C (zh) 2005-07-06
CA2407428C (en) 2010-02-02
KR20020093120A (ko) 2002-12-12
US6583288B2 (en) 2003-06-24
JP2003531905A (ja) 2003-10-28
AR034253A1 (es) 2004-02-18
BR0110492A (pt) 2003-04-08
AU2001252270B2 (en) 2005-12-15
US6784298B2 (en) 2004-08-31
ECSP014055A (es) 2002-01-25
PT1280801E (pt) 2005-11-30
ZA200208370B (en) 2004-01-26

Similar Documents

Publication Publication Date Title
ATE304011T1 (de) Hydantoin-enthaltende glucokinase aktivatoren
DK1169312T3 (da) Glucokinaseaktivatorer
DK1242397T3 (da) Trans-olefiniske glucokinaseaktivatorer
ATE297921T1 (de) Tetrazolylphenyl-acetamide als glukokinaseaktivatoren
DE60134470D1 (de) Para-amin substituierte phenylamid glukokinase activatoren
NO20030472D0 (no) Imidazolderivater
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
DE60131992D1 (de) Pfropfcopolymere enthaltende klebstoffe
DK1568367T5 (da) Glucokinase påvirkende forbindelser
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
ATE360620T1 (de) Imidazolderivate
DE50113706D1 (de) Träger
DE50009640D1 (de) Drehmaschine
DE50011953D1 (de) Bohrwerkzeug
NO20025659L (no) Heterocykliske forbindelser
DE50100739D1 (de) Drehmaschine
DE50011611D1 (de) Bohrwerkzeug
DE50113112D1 (de) Schaltungsanordnung
DE50102328D1 (de) Feuchttücher (i)
DE50110971D1 (de) Werkzeughalter
FI20001260L (fi) Kontti
DE50104260D1 (de) Behälter
DE50115426D1 (de) Schaltungsanordnung
FI20000173L (fi) Nesteen syöttäminen
FI20001704A0 (fi) Kontti

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1280801

Country of ref document: EP

REN Ceased due to non-payment of the annual fee